These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14684149)

  • 1. The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder.
    Okpala I
    Blood Rev; 2004 Mar; 18(1):65-73. PubMed ID: 14684149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells.
    Okpala I; Daniel Y; Haynes R; Odoemene D; Goldman J
    Eur J Haematol; 2002 Sep; 69(3):135-44. PubMed ID: 12406006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Neutrophil Adhesive Events to Address Vaso-Occlusive Crisis in Sickle Cell Patients.
    Morikis VA; Hernandez AA; Magnani JL; Sperandio M; Simon SI
    Front Immunol; 2021; 12():663886. PubMed ID: 33995392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell vaso-occlusion: The dialectic between red cells and white cells.
    Conran N; Embury SH
    Exp Biol Med (Maywood); 2021 Jun; 246(12):1458-1472. PubMed ID: 33794696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction.
    Nader E; Conran N; Romana M; Connes P
    Compr Physiol; 2021 Apr; 11(2):1785-1803. PubMed ID: 33792905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheology of the sickle cell disorders.
    Stuart J; Johnson CS
    Baillieres Clin Haematol; 1987 Sep; 1(3):747-75. PubMed ID: 3327564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophils as drivers of vascular injury in sickle cell disease.
    Torres LS; Hidalgo A
    Immunol Rev; 2023 Mar; 314(1):302-312. PubMed ID: 36251624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo.
    McMahon TJ; Shan S; Riccio DA; Batchvarova M; Zhu H; Telen MJ; Zennadi R
    Blood Adv; 2019 Sep; 3(17):2586-2597. PubMed ID: 31484636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.
    Alapan Y; Kim C; Adhikari A; Gray KE; Gurkan-Cavusoglu E; Little JA; Gurkan UA
    Transl Res; 2016 Jul; 173():74-91.e8. PubMed ID: 27063958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.
    Telen MJ; Batchvarova M; Shan S; Bovee-Geurts PH; Zennadi R; Leitgeb A; Brock R; Lindgren M
    Br J Haematol; 2016 Dec; 175(5):935-948. PubMed ID: 27549988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.
    Chang J; Shi PA; Chiang EY; Frenette PS
    Blood; 2008 Jan; 111(2):915-23. PubMed ID: 17932253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle red cell-endothelium interactions.
    Kaul DK; Finnegan E; Barabino GA
    Microcirculation; 2009 Jan; 16(1):97-111. PubMed ID: 18720225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
    Finnegan EM; Turhan A; Golan DE; Barabino GA
    Am J Hematol; 2007 Apr; 82(4):266-75. PubMed ID: 17094094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell vaso-occlusion: multistep and multicellular paradigm.
    Frenette PS
    Curr Opin Hematol; 2002 Mar; 9(2):101-6. PubMed ID: 11844991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of placental growth factor reduces vaso-occlusive complications in murine models of sickle cell disease.
    Gu JM; Yuan S; Sim D; Abe K; Liu P; Rosenbruch M; Bringmann P; Kauser K
    Exp Hematol; 2018 Apr; 60():73-82.e3. PubMed ID: 29337222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease.
    Telen MJ
    Hematology Am Soc Hematol Educ Program; 2007; ():84-90. PubMed ID: 18024614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium.
    Elion JE; Brun M; Odièvre MH; Lapouméroulie CL; Krishnamoorthy R
    Hematol J; 2004; 5 Suppl 3():S195-8. PubMed ID: 15190308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.